Regulatory mechanism of endothelin receptor b in the cerebral arteries after focal cerebral ischemia

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Grell, Anne Sofie ^a   Thigarajah, Rushani ^b   Edvinsson, Lars ^a,b   Samraj, Ajoy Kumar ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR B; MESSENGER RNA; MITHRAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; EDNRB PROTEIN, HUMAN; MITHRAMYCIN A;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFICACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MYOGRAPHY; NONHUMAN; ORGAN CULTURE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASOCONSTRICTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BRAIN CIRCULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; ORGAN CULTURE TECHNIQUE; PATHOLOGY;

RATTUS;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; ORGAN CULTURE TECHNIQUES; PLICAMYCIN; RATS; RECEPTORS, ENDOTHELIN; SP1 TRANSCRIPTION FACTOR; VASOCONSTRICTION;

EID: 84916889897     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113624     Document Type: Article

References (31)

1. Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415.
2. Nishigaya K, Yoshida Y, Sasuga M, Nukui H, Ooneda G (1991) Effect of recirculation on exacerbation of ischemic vascular lesions in rat brain. Stroke 22: 635-642.
3. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 22: 391-397.
4. Edvinsson LI, Povlsen GK (2011) Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab 31: 1554-1571.
5. Johansson S, Povlsen GK, Edvinsson L (2012) Expressional changes in cerebrovascular receptors after experimental transient forebrain ischemia. PLoS One 7: e41852.
6. Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas I, et al. (1997) Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 28: 1951-1955.
7. Matsuo Y, Mihara S, Ninomiya M, Fujimoto M (2001) Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats. Stroke 32: 2143-2148.
8. Zhang RL, Zhang C, Zhang L, Roberts C, Lu M, et al. (2008) Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke. Stroke 39: 2830- 2836.
9. Memezawa H, Minamisawa H, Smith ML, Siesjo BK (1992) Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 89: 67-78.
10. Ahnstedt H, Saveland H, Nilsson O, Edvinsson L (2011) Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway. BMC Neurosci 12: 5.
11. Povlsen GK, Waldsee R, Ahnstedt H, Kristiansen KA, Johansen FF, et al. (2012) In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries. Exp Brain Res 219: 507-520.
12. Henriksson M, Xu CB, Edvinsson L (2004) Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol 142: 1155-1161.
13. Roubert P, Gillard V, Plas P, Chabrier PE, Braquet P (1991) Binding characteristics of endothelin isoforms (ET-1, ET-2, and ET-3) in vascular smooth muscle cells. J Cardiovasc Pharmacol 17 Suppl 7: S104-108.
14. Chu S (2012) Transcriptional regulation by post-transcriptional modification-role of phosphorylation in Sp1 transcriptional activity. Gene 508: 1-8.
15. Yeh SH, Yang WB, Gean PW, Hsu CY, Tseng JT, et al. (2011) Translational and transcriptional control of Sp1 against ischaemia through a hydrogen peroxide-activated internal ribosomal entry site pathway. Nucleic Acids Res 39: 5412-5423.
16. Van Dyke MW, Dervan PB (1983) Chromomycin, mithramycin, and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron(II). Biochemistry 22: 2373-2377.
17. Snyder RC, Ray R, Blume S, Miller DM (1991) Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30: 4290-4297.
18. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, et al. (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88: 1613-1621.
19. Tan NY, Khachigian LM (2009) Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 29: 2483-2488.
20. Milanini-Mongiat J, Pouyssegur J, Pages G (2002) Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: Their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277: 20631-20639.
21. Ansar S, Eftekhari S, Waldsee R, Nilsson E, Nilsson O, et al. (2013) MAPK signaling pathway regulates cerebrovascular receptor expression in human cerebral arteries. BMC Neurosci 14: 12.
22. D'Orleans-Juste P, Claing A, Warner TD, Yano M, Telemaque S (1993) Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br J Pharmacol 110: 687-692.
23. Ehrenreich H, Schilling L (1995) New developments in the understanding of cerebral vasoregulation and vasospasm: The endothelin-nitric oxide network. Cleve Clin J Med 62: 105-116.
24. Henriksson M, Stenman E, Edvinsson L (2003) Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 34: 1479-1483.
25. Hagiwara H, Iyo M, Hashimoto K (2009) Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine. Brain Res 1301: 189-196.
26. Chatterjee S, Zaman K, Ryu H, Conforto A, Ratan RR (2001) Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons. Ann Neurol 49: 345-354.
27. Merchant JL, Du M, Todisco A (1999) Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun 254: 454-461.
28. Sleiman SF, Langley BC, Basso M, Berlin J, Xia L, et al. (2011) Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J Neurosci 31: 6858-6870.
29. Maddahi A, Chen Q, Edvinsson L (2009) Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci 10: 56.
30. Dutcher JP, Coletti D, Paietta E, Wiernik PH (1997) A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia. Leuk Res 21: 375-380.
31. Kennedy BJ, Torkelson JL (1995) Long-term follow-up of stage III testicular carcinoma treated with mithramycin (plicamycin). Med Pediatr Oncol 24: 327-328.